Guangzhou Baiy | 600332 - Operating Expenses


Guangzhou Baiy reported CNY21.02B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Aspen Pharmacare ZAR 13.32B 5.36B Dec/2025
Cipla INR 59.27B 1.71B Mar/2026
Dr.Reddys Laboratories INR 74.58B 977M Mar/2026
Jiangsu Hengrui CNY 5.52B 604.29M Mar/2026
Kalbe Farma IDR 8.06T 883.47B Sep/2025
Richter Gedeon HUF 157.88B 6.77B Mar/2026
Sh Fosun Pharma CNY 9.18B 2.12B Mar/2026
Sh Pharmaceutical CNY 66.41B 5.25B Dec/2025
Sun Pharmaceuticals INR 114.07B 2.96B Dec/2025
Teva Pharmaceutical Industries USD 3.22B 1000M Mar/2026